TrialThe American journal of cardiology2010

Efficacy and safety of adding fenofibrate 160 mg in high-risk patients with mixed hyperlipidemia not controlled by pravastatin 40 mg monotherapy.

Michel Farnier et al.PubMed ↗Publisher ↗

No numbers read from the abstract.